A worse prognosis for incomplete revascularization in both angioplasty and surgery.

Original title: The Negative Impact of Incomplete Angiographic Revascularization on Clinical Outcomes and Its Association With Total Occlusions. The SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) Trial. Reference: Vasim Farooq et al. J Am Coll Cardiol 2013;61:282–94

In patients with complex coronary artery disease who underwent coronary artery bypass surgery, (CABG), or percutaneous transluminal coronary angioplasty, (PTCA), the long-term prognosis of complete versus incomplete revascularization is unclear. 

In fact, recent studies suggest that complete revascularization when receiving CABG does not significantly improve the long-term prognosis. The aim of this study was to report the long-term clinical impact, (4 years), of the complete or incomplete angiography revascularization in all patients, “all-comers”, of the SYNTAX study, (both randomized and those included in the record of CABG and PTCA). With a total of 2,636 patients, complete revascularization was achieved in 52.8% of those receiving PTCA, (n = 1095), and 66.9% of those receiving CABG, (n = 1541). 

Patients with incomplete revascularization had a greater anatomical complexity, (high SYNTAX score and total occlusions), more comorbidities, (higher EuroSCORE), and a lower incidence of injury to the left coronary trunk. In both branches incomplete revascularization, (compared to complete), was associated with a significant increase in mortality at 4 years, of revascularization, stent thrombosis and major cardiovascular and cerebrovascular events (MACCE). The biggest predictor of incomplete revascularization for PTCA branch were total occlusions and for the CABG branch left dominance. Complete revascularization in patients with total occlusions was associated with lower stent thrombosis at 4 years in the PTCA branch as well as minor occlusion of the bridges in the CABG branch.

Conclusion: 

In both branches, angioplasty and surgery, incomplete angiographic revascularization seems to be connected to anatomical complexity and clinical comorbidities. It has a long-term negative impact on all events including mortality.

Editorial Comment: 

The results of this post hoc study should be considered as hypothesis but generating, nevertheless, many interesting facts. For example, patients with incomplete revascularization presented high stent thrombosis despite receiving fewer stents and the total length was significantly less treated. This could be explained by a more challenging anatomy with a poor distal bed and severe calcification. In the CABG branch patients with complete revascularization without occlusions had higher occlusions of the bridges that those that had total occlusions. Perhaps the bridges connected to uninjured arteries actually present flow competition and tend to occlude over time. Finally, the concepts of “reasonable” or “acceptable” revascularization are emerging but it is unclear what percentage of ischemic myocardium we can “tolerate” and if angiography should be replaced by the fractional flow reserve, (FFR), to complete the divide of incomplete occlusions.

SOLACI.ORG

More articles by this author

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

LDL cholesterol is a well-established factor for cardiovascular disease. Therapy with PCSK9 inhibitors, including evolocumab, has been shown to reduce the risk of cardiovascular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....